Filters

Matt S Anderson, William D Hanley, Allison R Moreau, Bo Jin, Frederick A Bieberdorf, James T Kost, Larissa A Wenning, Julie A Stone, John A Wagner, Marian Iwamoto

British journal of clinical pharmacology 2011;71(4):616-20

Free Full Text

Abstract

The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa.

M T Muñoz, G Morandé, J A García-Centenera, F Hervás, J Pozo, J Argente

European journal of endocrinology 2002;146(1):45-50

Full Text

Abstract

Comparison of norgestrel- versus cyproterone acetate-containing hormone replacement therapy on lipid-lipoprotein metabolism.

K Panyakhamlerd, K Limpaphayom, N Taechakraichana, S Chaikittisilpa, S Pasatrat, S Pojanasopanakun

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2000;83(7):764-70

Full Text

Abstract

Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.

Jules I Schwartz, Fang Liu, Ying-Hong Wang, Barnali Pramanik, Amy O Johnson-Levonas, Maria J Gutierrez, Eseng Lai, John A Wagner

American journal of therapeutics 2010;16(6):487-95

Full Text

Abstract

Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.

Giuseppe Bifulco, Mariangela Massaro, Carmen Formisano, Virginia Gargano, Costantino Di Carlo, Carmine Nappi

Contraception 2010;81(3):209-14

Full Text

Abstract

A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles.

R A Lobo, H Z Zacur, P Caubel, R Lane

American journal of obstetrics and gynecology 2000;182(1 Pt 1):41-9

Free Full Text

Abstract

Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.

Marie Bakowski, Diana Jesinger, Diana Cieraad, Christian Conradt

Archives of gynecology and obstetrics 2007;274(2):74-80

Full Text

Abstract

Results: 1 – 15 / 24

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Norgestrel""[mesh_terms]

Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.

Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.

Role of the combination spironolactone-norgestimate-estrogen in Hirsute women with polycystic ovary syndrome.

Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.

Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.

Lack of effect of a high-fat meal on the bioavailability of 17 beta-estradiol/norgestimate in healthy postmenopausal women.

Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.

Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours.

Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women.

The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa.

Comparison of norgestrel- versus cyproterone acetate-containing hormone replacement therapy on lipid-lipoprotein metabolism.

Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.

Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.

A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles.

Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.

Results for
""Norgestrel""[mesh_terms]